Literature DB >> 24824927

MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells.

X Li, F S Wang, Z Y Wu, J L Lin, W B Lan, J H Lin.   

Abstract

Accumulative evidence has confirmed that, miR-17-92, a typical polycistronic mRNA cluster, was up-regulated in various solid tumors, and play an important role in the occurrence and development progress of tumors. In our study, we detected the six members of miR-17-92 cluster in osteosarcoma cell line, finding that the expression of miR-17 and miR-19b was up-regulated significantly. Further studies have found that Mfn1 was one of the target genes of miR-19b and the transcription and expression level of Mfn1 were down-regulated by miR-19b. MTS, flow cytometry, TUNEL-DAPI, Annexin V-FITC and transwell assay demonstrated that Mfn1 significantly blocked the cell cycle, promoted apoptosis and inhibited proliferation and invasion of osteosarcoma cells. Whereas, miR-19b targets 3'UTR sequences of Mfn1 genes inhibit the expression of Mfn1, thus inhibited Mfn1 triggered anti-cancer effect. Taken together, miR-19b functions by targeting Mfn1 reduce the protein expression level, thus provides a novel target to understand the molecular biology and genetics mechanisms of occurrence and development of osteosarcoma, contributing to the diagnosis and therapy of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24824927     DOI: 10.4149/neo_2014_034

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  12 in total

Review 1.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

2.  Long Noncoding RNA LINC00839 Promotes the Malignant Progression of Osteosarcoma by Competitively Binding to MicroRNA-454-3p and Consequently Increasing c-Met Expression.

Authors:  Yang Zhang; Hai Guo; Li Ma; Xiaoyong Chen; Guangdong Chen
Journal:  Cancer Manag Res       Date:  2020-09-24       Impact factor: 3.989

3.  Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion.

Authors:  Yi-Xin Du; Lin-Xin Guo; Han-Song Pan; Yi-Min Liang; Xiang Li
Journal:  Hum Cell       Date:  2019-10-30       Impact factor: 4.174

4.  miR-27 regulates mitochondrial networks by directly targeting the mitochondrial fission factor.

Authors:  Hyosun Tak; Jihye Kim; Aravinth Kumar Jayabalan; Heejin Lee; Hoin Kang; Dong-Hyung Cho; Takbum Ohn; Suk Woo Nam; Wook Kim; Eun Kyung Lee
Journal:  Exp Mol Med       Date:  2014-11-28       Impact factor: 8.718

5.  microRNA-200a-3p enhances mitochondrial elongation by targeting mitochondrial fission factor.

Authors:  Heejin Lee; Hyosun Tak; So Jung Park; Yoon Kyung Jo; Dong Hyung Cho; Eun Kyung Lee
Journal:  BMB Rep       Date:  2017-04       Impact factor: 4.778

Review 6.  Mitochondrial network structure homeostasis and cell death.

Authors:  Long-Long Xie; Feng Shi; Zheqiong Tan; Yueshuo Li; Ann M Bode; Ya Cao
Journal:  Cancer Sci       Date:  2018-11-16       Impact factor: 6.716

7.  Mitochondrial Dynamics Related Genes -MFN1, MFN2 and DRP1 Polymorphisms are Associated with Risk of Lung Cancer.

Authors:  Xiaohua Liang; Shengqiang Dang
Journal:  Pharmgenomics Pers Med       Date:  2021-06-14

Review 8.  Novel Insights into Insect-Microbe Interactions-Role of Epigenomics and Small RNAs.

Authors:  Dohyup Kim; Margaret W Thairu; Allison K Hansen
Journal:  Front Plant Sci       Date:  2016-08-04       Impact factor: 5.753

9.  MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.

Authors:  Li-Hui Bian; Jing-Ling Duan; Chen Zhou; Guo-Wen Shen; Xiao-Yu Wang; Yang Yang; Xiao-Ling Zhang; Sheng-Jun Xiao
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952

10.  miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway.

Authors:  Chuansheng Li; Jingwei Zhang; Zhongliang Ma; Fan Zhang; Wenlong Yu
Journal:  Onco Targets Ther       Date:  2018-07-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.